MicroRNA-148b and its Role in Gastric Cancer
Author Information
Author(s): Song Yong-Xi, Yue Zhen-Yu, Wang Zhen-Ning, Xu Ying-Ying, Luo Yang, Xu Hui-Mian, Zhang Xue, Jiang Li, Xing Cheng-Zhong, Zhang Yong
Primary Institution: First Hospital of China Medical University
Hypothesis
The study aims to elucidate the molecular mechanisms by which miR-148b acts as a tumor suppressor in gastric cancer.
Conclusion
MiR-148b is significantly down-regulated in gastric cancer and inhibits cell proliferation by targeting CCKBR.
Supporting Evidence
- MiR-148b was down-regulated in 106 gastric cancer tissues compared to non-tumor tissues.
- 62.26% of gastric cancer cases showed more than 50% reduction in miR-148b levels.
- MiR-148b inhibited cell proliferation in vitro and suppressed tumor growth in vivo.
- CCKBR was identified as a target of miR-148b, showing an inverse correlation with miR-148b expression.
Takeaway
This study found that a tiny molecule called miR-148b is often missing in stomach cancer, and it helps stop cancer cells from growing.
Methodology
The study used real-time RT-PCR, in situ hybridization, and various cell assays to analyze miR-148b expression and its effects on gastric cancer cells.
Limitations
The study does not explore the full range of miR-148b's potential targets or its mechanisms in different cancer types.
Participant Demographics
Patients diagnosed with gastric cancer, with a sample size of 106.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website